Important safety information about your treatment for generalised Myasthenia Gravis (gMG).
WHAT DO I NEED TO KNOW BEFORE STARTING TREATMENT?
If you are allergic to the active ingredient (ravulizumab) or any of the other ingredients of this medicine...
VACCINATION
This medicine increases your risk of meningococcal infection (caused by Neisseria meningitidis) and other general infections. Infections triggered by Neisseria meningitidis...
VACCINATION SCHEDULE
This medicine puts you at higher risk for meningococcal infections and therefore you should receive...
WHAT SHOULD ALERT ME
Should you experience any signs of meningococcal infection despite being vaccinated, it’s crucial to immediately identify the symptoms and start antibiotic treatment without delay...
TREATMENT FOR MENINGOCOCCAL INFECTION WHILE TRAVELLING
If you are travelling in a region where you are unable to contact your doctor or will be temporarily unable to...
POSSIBLE SIDE EFFECTS
Like all medicines, Ultomiris can cause side effects, although not everybody gets them. Your doctor will discuss the possible side effects with you and explain the risks and...
Reporting SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not...
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient leaflet. You can also report side effects directly via the national reporting system [Country to add their Regulatory Authority website]. Side effects should also be reported to Alexion by contacting https://contactazmedical.astrazeneca.com. By reporting side effects, you can help provide information on the safety of this medicine.